ClinicalTrials.gov
public full text
Public Domain
Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions
This study is a 12-week randomized-controlled trial of memantine hydrochloride (Namenda) for the treatment of social impairment in youth with Non-Verbal Learning Disorder, High-Functioning Autism Spectrum Disorder, and related conditions. Eligible participants will be males and females ages 8-18. This study consists of up to 6 visits to Massachusetts General Hospital.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Neurodevelopmental and Behavioral Phenotyping Screening Protocol#882137
- Effect of Childhood Radioiodine Therapy on Salivary Function#913957
- Assessment of Vitamin D Level in Children With Autism in Assiut University Children Hospital#874260
- A Validity Study of the Childhood Autism Rating Scale With Autistic Adolescents: Two Methods#393713
- Bienestar psicológico, apoyo social y características de personalidad de padres de niños con autismo y de niños con Síndrome de Down.#211828
Record · ID 893860
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive